T cell Activation does not drive CD4 decline in longitudinally followed HIV-infected Elite Controllers
Authors:
- Philomena KamyaPKPhilomena Kamya
- Christos M TsoukasCTChristos M Tsoukas
- Salix BouletSBSalix Boulet
- Jean-Pierre RoutyJRJean-Pierre Routy
- Réjean ThomasRTRéjean Thomas
- Pierre CôtéPCPierre Côté
- Mohamed-Rachid BoulasselMBMohamed-Rachid Boulassel
- Bernard LessardBLBernard Lessard
- Rupert KaulRKRupert Kaul
- Mario OstrowskiMOMario Ostrowski
- Colin KovacsCKColin Kovacs
- Cecile L TremblayCTCecile L Tremblay
Open Access
- 16 June 2011
- journal article
- research article
- Published by Springer Nature in AIDS Research and Therapy
- Vol. 8 (1) , 20
Abstract
Elite controllers (EC) are a rare subset of HIV infected individuals who control viral load below 50 copies/ml of plasma without treatment. Thirty four EC were studied. The slope of CD4 count change was available for 25 of these subjects. We assessed immune activation by measuring the percent of CD38+HLA-DR+CD8+ T cells in the EC group and comparing it with that in 24 treatment-naïve HIV disease progressors and 13 HIV uninfected healthy controls. Compared to HIV uninfected subjects, EC had higher percentages of CD38+HLA-DR+CD8+ T cells (p < 0.001) that was lower than that observed in progressors (p < 0.01). Fifteen of 25 EC had a slope of CD4 count change that was not significantly different from 0 while 3 had a positive and 7 a negative CD4 count slope. Immune activation did not distinguish EC subsets with stable/increasing versus declining CD4 counts. Elevated immune activation in ECs is not associated with a faster rate of CD4 declineKeywords
This publication has 27 references indexed in Scilit:
- T Cell Dynamics and the Response to HAART in a Cohort of HIV‐1–Infected Elite SuppressorsClinical Infectious Diseases, 2009
- Clinical Outcomes of Elite Controllers, Viremic Controllers, and Long‐Term Nonprogressors in the US Department of Defense HIV Natural History StudyThe Journal of Infectious Diseases, 2009
- Persistent Low‐Level Viremia in HIV‐1 Elite Controllers and Relationship to Immunologic ParametersThe Journal of Infectious Diseases, 2009
- Prevalence and comparative characteristics of long-term nonprogressors and HIV controller patients in the French Hospital Database on HIVAIDS, 2009
- Evidence for Persistent Low-Level Viremia in Individuals Who Control Human Immunodeficiency Virus in the Absence of Antiretroviral TherapyJournal of Virology, 2009
- A Comparison of Viral Loads between HIV‐1–Infected Elite Suppressors and Individuals Who Receive Suppressive Highly Active Antiretroviral TherapyClinical Infectious Diseases, 2008
- CD4+T Cell Depletion in an Untreated HIV Type 1–Infected Human Leukocyte Antigen–B*5801–Positive Patient with an Undetectable Viral LoadClinical Infectious Diseases, 2008
- Relationship between T Cell Activation and CD4+T Cell Count in HIV‐Seropositive Individuals with Undetectable Plasma HIV RNA Levels in the Absence of TherapyThe Journal of Infectious Diseases, 2008
- HIV controllers exhibit potent CD8 T cell capacity to suppress HIV infection ex vivo and peculiar cytotoxic T lymphocyte activation phenotypeProceedings of the National Academy of Sciences, 2007
- CD4+ T-cell depletion in HIV infection: Are we closer to understanding the cause?Nature Medicine, 2002